US obesity falls, but diabetes continues to rise

For the first time in a while, obesity numbers are dropping in the U.S.  Some believe it is due to the use of popular GLP-1s such as Mounjaro and Ozempic, but while those drugs may be making people thinner, diabetes rates are on the rise. So what gives? Greg and Holly discuss.